Management Presentation: Biosimilar Pipeline and Margin Improvement Strategy slide image

Management Presentation: Biosimilar Pipeline and Margin Improvement Strategy

Global scale and a European champion Net sales by region FY 2022, in USD International 2.5bn North America Market leadership and strong growth in Europe Capturing high-growth / high-return opportunities in International markets North America stabilizing Europe 4.5bn 27% +7% 1 SANDOZ +6% 1 50% 9.1bn +4%1 23% 2.1bn -2%1 Note: Net sales to third parties based on unaudited carve-out financials extract. Numbers may not add up due to rounding; 1. Growth vs. 2021 in constant currencies. For additional information regarding constant currencies, which is a non-IFRS measure, see "Appendix" starting on slide 31 8 Management Presentation SANDOZ
View entire presentation